Brach Eichler Talks | Law & Legal Insights from Lawyers

NJ Businesses Must Now Report All Employment Separations

NJ Businesses Must Now Report All Employment Separations
All New Jersey employers, regardless of size, are now required to report employee separations through the New Jersey Department of Labor’s online Employer Response Portal. In this episode of Brach Eichler Talks, we break down what this new requirement means, key deadlines to know, and the potential penalties for noncompliance.
We cover:
Who must report employment separations
What information must be submitted
How soon employers must act
How this requirement fits alongside Form BC-10 obligations
Compliance risks and best practices for employers
Employers should ensure internal termination procedures are updated and that HR and legal teams understand how to properly document separation reasons—especially in involuntary terminations.
🔗 Important Links Referenced in This Episode:Employer Response Portal:https://www.nj.gov/labor/ea/employer-services/register-update/employeraccess.shtml
Form BC-10 (Unemployment Instructions):https://www.nj.gov/labor/forms_pdfs/ui/BC10.pdf
📲 Read the full alert here: https://www.bracheichler.com/insights/nj-businesses-must-now-report-all-employment-separations/
For guidance on compliance and risk mitigation, contact Brach Eichler’s Labor & Employment attorneys:
Jay Sabin, Esq. – 917.596.8987 | jsabin@bracheichler.com | https://www.bracheichler.com/professionals/jay-sabin/
Sarah A. Gober, Esq. – 973.364.8375 | sgober@bracheichler.com | https://www.bracheichler.com/professionals/sarah-a-gober/
*This is meant to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

COVID-19 State of Emergency Ends – APNs and Other Healthcare Providers Impacted

New Jersey’s COVID-19 State of Emergency officially ends on February 16, 2026, bringing major regulatory changes for advanced practice nurses (APNs), physician assistants (PAs), and healthcare providers statewide. In this episode, Brach Eichler’s Healthcare Law team breaks down Executive Order No. 415, what flexibilities are expiring, and how providers should prepare for renewed compliance requirements.
We also discuss Senate Bill 2996, proposed legislation that could significantly expand independent practice authority for certain experienced APNs, and what it may mean for healthcare facilities, supervision models, and patient care.
This episode is essential listening for healthcare administrators, compliance officers, APNs, PAs, physicians, and healthcare organizations operating in New Jersey.
📲 Read the full alert now: https://www.bracheichler.com/insights/covid-19-state-of-emergency-ends-apns-and-other-healthcare-providers-impacted/
If you have questions or require additional information, please contact
John D. Fanburg, Esq., Managing Member and Chair, Healthcare Law, jfanburg@bracheichler.com, 973.403.3107
Edward Hilzenrath, Esq., Member, Healthcare Law, ehilzenrath@bracheichler.com, 973.403.3114
Rebecca T. Falk, Esq., Associate, Healthcare Law, rfalk@bracheichler.com, 973.364.8393
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific advice.
Episode Markers / Timestamps
00:00 – Overview: End of NJ COVID-19 State of Emergency02:15 – Executive Order No. 415: What officially changes05:10 – APNs: Return to joint protocol and prescriptive authority requirements08:40 – Physician Assistants: Supervision and delegation agreements reinstated11:20 – Temporary and out-of-state licenses: Transition requirements13:45 – Senate Bill 2996 explained: Expanded APN scope of practice17:30 – What healthcare facilities should do now to ensure compliance20:10 – Key takeaways and next steps for NJ healthcare providers

NJDEP Releases Updated LSRP Supplemental Certification for Initial GW RAP Application for MNA

In this episode, Brach Eichler attorneys Frances B. Stella and Lindsay P. Cambron discuss NJDEP’s updated LSRP Supplemental Certification for Initial Ground Water RAP Applications involving Monitored Natural Attenuation (MNA). They highlight key changes to the form, explain why the updates were made, and outline what they mean for site remediation and permitting in New Jersey.
📲 Read the full post now: https://www.bracheichler.com/insights/njdep-releases-updated-lsrp-supplemental-certification-for-initial-gw-rap-application-for-mna/
Questions about how these updates may affect your project? Contact:
Frances B. Stella📞 973.403.3149 | ✉️ fstella@bracheichler.com
Lindsay P. Cambron📞 973.364.5232 | ✉️ lcambron@bracheichler.com
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

AI Transcription Bots: The Legal Risks and the Need for Organizational AI Policies

AI transcription bots are becoming a routine part of video calls, but their convenience can come with serious legal and compliance risks. In this episode, we break down key issues organizations need to understand before relying on AI-generated call recordings and summaries. Read the full alert at https://www.bracheichler.com/insights/ai-transcription-bots-the-legal-risks-and-the-need-for-organizational-ai-policies/
Our discussion covers confidentiality concerns involving attorney-client privilege, HIPAA-protected information, and sensitive business data, as well as the risk of inaccurate or misleading AI summaries, expanded litigation exposure, and consent and notice requirements across jurisdictions. We also explore why these tools underscore the growing need for clear, well-structured organizational AI policies.
To learn more about managing AI risks in your workplace or developing AI policies and procedures, contact:
Lani M. Dornfeld, Esq., CHPCMember, Healthcare Law Practice📞 973.403.3136📧 ldornfeld@bracheichler.com
Jay Sabin, Esq.Member, Labor and Employment Practice📞 917.596.8987📧 jsabin@bracheichler.com
👉 Listen to the full episode and reach out to our team to discuss how these issues may affect your organization.
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

Navigating New Jersey's Inheritance Tax: What You Need to Know in 2026

In this episode, Brach Eichler’s Trusts and Estates team takes a practical look at inheritance tax planning and compliance, with a focus on how thoughtful planning can help families protect and transfer wealth efficiently. Counsel Amy Van Fossen breaks down key considerations surrounding inheritance and related tax obligations, common pitfalls to avoid, and strategies that can help minimize tax exposure while meeting legal requirements.
Amy shares insight drawn from her extensive experience in sophisticated estate planning and administration, including the use of wills, trusts, and advanced planning tools for high-net-worth individuals and multi-generational families. Listeners will gain a clearer understanding of how inheritance tax issues fit into a broader estate plan and why proactive planning is critical.
🎧 Tune in for a clear, informative discussion designed to help individuals, families, and advisors navigate inheritance tax issues with confidence.
For more information, contact:- Amy Van Fossen, Counsel, Trusts and Estates at 973.447.9675, avanfossen@bracheichler.com, or https://www.bracheichler.com/professionals/amy-van-fossen/
*This is intended to provide general information, not legal advice. Please contact Amy if you need specific legal advice.

The FMLA In Focus: Recently Issued Guidance About Calculating Leave Entitlements for Intermittent and Reduced Schedule Leaves

In this episode of The FMLA In Focus, Brach Eichler’s Labor and Employment attorneys break down newly issued guidance from the U.S. Department of Labor on how employers should calculate FMLA leave entitlements when leave is taken intermittently or on a reduced schedule.
We discuss how to properly convert the 12-week FMLA entitlement into hours, address variable work schedules, mandatory overtime considerations, and how schedule changes before or during leave can impact both entitlement and usage calculations. Employers will gain practical insights to help ensure compliance and avoid common missteps when administering FMLA leave.
🎧 Listen in for a clear, employer-focused overview of what this guidance means for your organization and how to apply it in practice.
👉 Learn more and read the full alert at: https://www.bracheichler.com/insights/the-fmla-in-focus-recently-issued-guidance-about-calculating-leave-entitlements-for-intermittent-and-reduced-schedule-leaves/
For more information, contact:
Jay Sabin, Esq. – Member, Labor & Employment📞 917.596.8987 | ✉️ jsabin@bracheichler.com
Sarah A. Gober, Esq. – Counsel, Labor & Employment📞 973.364.8375 | ✉️ sgober@bracheichler.com
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

CMS Finalizes Calendar Year 2026 Medicare Physician Fee Schedule

In this episode, Brach Eichler’s Healthcare Law team breaks down the key updates in CMS’s Calendar Year 2026 Medicare Physician Fee Schedule Final Rule. We review changes to payment rates, adjustments for QP and non-QP providers, new telehealth flexibilities, supervision standards, and important updates affecting Part B drug reimbursement and inflation-rebate calculations.
Tune in for a clear, practical overview of what providers need to know before the rule takes effect on January 1, 2026.
📲 Read the full article now: https://www.bracheichler.com/insights/cms-finalizes-calendar-year-2026-medicare-physician-fee-schedule/
For more information, contact:Caroline Patterson – 973.364.5233 – cpatterson@bracheichler.comJonathan J. Walzman – 973.403.3120 – jwalzman@bracheichler.comAndrew M. Kuder – 973.403.3141 – akuder@bracheichler.com
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

Feds, Pharma Companies Strike Deal for Low Cost GLP-1 Medications

In this episode, the Brach Eichler Healthcare Law team breaks down the federal government’s newly announced agreement with Eli Lilly and Novo Nordisk to dramatically reduce the cost of popular GLP-1 medications—including Ozempic, Wegovy, Zepbound, and future oral GLP-1 tablets. We explore what this landmark deal means for Medicare and Medicaid beneficiaries, cash-pay patients, and healthcare providers, as well as its connection to the administration’s Most-Favored-Nation drug pricing initiative.
Our attorneys explain key price changes, the launch of the TrumpRx purchasing platform, expanded obesity-drug coverage under Medicare, and pharmaceutical manufacturers’ massive U.S.-based investments.
Tune in for clear, practical insights on how these policy shifts may impact prescribing, patient access, and the broader healthcare delivery landscape.
📲 Read the full article now at https://www.bracheichler.com/insights/feds-pharma-companies-strike-deal-for-low-cost-glp-1-medications/
For more information, contact:John D. Fanburg, Chair – 973.403.3107 – jfanburg@bracheichler.comRichard B. Robins – 973.447.9663 – rrobins@bracheichler.comAndrew M. Kuder – 973.403.3141 – akuder@bracheichler.com
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.